A spotlight on Brexit; what does the future hold for UK drug patent legislation?

被引：0
作者：
Watson, Robert [1 ]
机构：
[1] Mewburn Ellis LLP, City Tower,40 Basinghall St, London EC2V 5DE, England
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2019年 / 29卷 / 04期
关键词：
Brexit; patent; SPC; regulation;
D O I：
10.1080/13543776.2019.1590335
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：215 / 216
页数：2
相关论文
共 5 条
  • [1] European Union (Withdrawal) Act 2018
  • [2] Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, as endorsed by leaders at a special meeting of the European Council on 25 November 2018
  • [3] Political Declaration setting out the framework for the future relationship between the European Union and the United Kingdom, 25 November 2018
  • [4] Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products
  • [5] The Patents (Amendment)(EU Exit) Regulations 2018
1